Consistent with this, the IHC assay showed high levels of the early autophagy markers LC3 (Figure 4H) and BECLIN/ATG5 (data not shown) in the Huaier-treated pancreatic tumour group, but the level of late autophagy markers P62 did not differ between the control and Huaier groups (Figure 4H). The gene discussed is ATG5; the disease is pancreatic neoplasm.